Work

Cadonilimab in combination with ivonescimab and chemotherapy as first-line (1L) therapy in patients with advanced gastric (G) or gastroesophageal junction adenocarcinoma (GEJA).

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e16037

Authors: Guangyu Wang, Chunhui Zhang, Jiebing Tang, Zhigang Ma, Dan Su, Yanqiao Zhang

Institution: Third Affiliated Hospital of Harbin Medical University

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410809918

FWCI: 0.608

Cites:

Cited by: 1

Related to: 10